179 related articles for article (PubMed ID: 31270081)
1. STAT3β is a tumor suppressor in acute myeloid leukemia.
Aigner P; Mizutani T; Horvath J; Eder T; Heber S; Lind K; Just V; Moll HP; Yeroslaviz A; Fischer MJM; Kenner L; Győrffy B; Sill H; Grebien F; Moriggl R; Casanova E; Stoiber D
Blood Adv; 2019 Jul; 3(13):1989-2002. PubMed ID: 31270081
[TBL] [Abstract][Full Text] [Related]
2. A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia.
Edtmayer S; Witalisz-Siepracka A; Zdársky B; Heindl K; Weiss S; Eder T; Dutta S; Graichen U; Klee S; Sharif O; Wieser R; Győrffy B; Poli V; Casanova E; Sill H; Grebien F; Stoiber D
Cell Death Dis; 2024 May; 15(5):369. PubMed ID: 38806478
[TBL] [Abstract][Full Text] [Related]
3. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
[TBL] [Abstract][Full Text] [Related]
4. Stat3 and G-CSF-induced myeloid differentiation.
Chakraborty A; Tweardy DJ
Leuk Lymphoma; 1998 Aug; 30(5-6):433-42. PubMed ID: 9711905
[TBL] [Abstract][Full Text] [Related]
5. STAT3beta, a distinct isoform from STAT3.
Zhang HX; Yang PL; Li EM; Xu LY
Int J Biochem Cell Biol; 2019 May; 110():130-139. PubMed ID: 30822557
[TBL] [Abstract][Full Text] [Related]
6. Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.
Huang Y; Qiu J; Dong S; Redell MS; Poli V; Mancini MA; Tweardy DJ
J Biol Chem; 2007 Nov; 282(48):34958-67. PubMed ID: 17855361
[TBL] [Abstract][Full Text] [Related]
7. Antitumorigenic potential of STAT3 alternative splicing modulation.
Zammarchi F; de Stanchina E; Bournazou E; Supakorndej T; Martires K; Riedel E; Corben AD; Bromberg JF; Cartegni L
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17779-84. PubMed ID: 22006329
[TBL] [Abstract][Full Text] [Related]
8. Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes.
Ng IH; Ng DC; Jans DA; Bogoyevitch MA
Biochem J; 2012 Oct; 447(1):125-36. PubMed ID: 22799634
[TBL] [Abstract][Full Text] [Related]
9. STAT3 isoforms: Alternative fates in cancer?
Aigner P; Just V; Stoiber D
Cytokine; 2019 Jun; 118():27-34. PubMed ID: 30031681
[TBL] [Abstract][Full Text] [Related]
10. STAT3beta does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation.
de Koning JP; Ward AC; Caldenhoven E; de Groot RP; Löwenberg B; Touw IP
Hematol J; 2000; 1(4):220-5. PubMed ID: 11920194
[TBL] [Abstract][Full Text] [Related]
11. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23.
Wang X; Guo J; Che X; Jia R
Int J Biol Sci; 2019; 15(6):1177-1186. PubMed ID: 31223278
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.
Narayanan P; Man TK; Gerbing RB; Ries R; Stevens AM; Wang YC; Long X; Gamis AS; Cooper T; Meshinchi S; Alonzo TA; Redell MS
Clin Transl Oncol; 2021 Oct; 23(10):2141-2154. PubMed ID: 33948920
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer.
Bharadwaj U; Kasembeli MM; Eckols TK; Kolosov M; Lang P; Christensen K; Edwards DP; Tweardy DJ
Cancers (Basel); 2014 Sep; 6(4):2012-34. PubMed ID: 25268166
[TBL] [Abstract][Full Text] [Related]
14. Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern.
Redell MS; Tsimelzon A; Hilsenbeck SG; Tweardy DJ
J Leukoc Biol; 2007 Oct; 82(4):975-85. PubMed ID: 17634277
[TBL] [Abstract][Full Text] [Related]
15. Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock.
Yoo JY; Huso DL; Nathans D; Desiderio S
Cell; 2002 Feb; 108(3):331-44. PubMed ID: 11853668
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide-directed STAT3 alternative splicing switch drives anti-tumorigenic outcomes in MCF10 human breast cancer cells.
Tano V; Jans DA; Bogoyevitch MA
Biochem Biophys Res Commun; 2019 Jun; 513(4):1076-1082. PubMed ID: 31010684
[TBL] [Abstract][Full Text] [Related]
17. Functional differences between Stat3alpha and Stat3beta.
Schaefer TS; Sanders LK; Park OK; Nathans D
Mol Cell Biol; 1997 Sep; 17(9):5307-16. PubMed ID: 9271408
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.
Schemionek M; Kharabi Masouleh B; Klaile Y; Krug U; Hebestreit K; Schubert C; Dugas M; Büchner T; Wörmann B; Hiddemann W; Berdel WE; Brümmendorf TH; Müller-Tidow C; Koschmieder S
PLoS One; 2015; 10(5):e0125783. PubMed ID: 25996952
[TBL] [Abstract][Full Text] [Related]
19. Of alphas and betas: distinct and overlapping functions of STAT3 isoforms.
Dewilde S; Vercelli A; Chiarle R; Poli V
Front Biosci; 2008 May; 13():6501-14. PubMed ID: 18508676
[TBL] [Abstract][Full Text] [Related]
20. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
